Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey

Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey

Bibliographic Details
Main Authors:	Tiago Jeronimo Dos Santos, Chetankumar Dave, Sarah MacLeish, Jamie R Wood
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-12-01
Series:	BMJ Open Diabetes Research & Care
Online Access:	https://drc.bmj.com/content/9/2/e002537.full

Similar Items

The Commonwealth ministers reference book /
by: MacLeish, Martin, et al.
Published: (1989)

Worldwide burden of diabetes
by: Jaikrit Bhutani, et al.
Published: (2014-01-01)

Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia.
by: Riswandy Wasir, et al.
Published: (2019-01-01)

The worldwide epidemic of diabetic retinopathy
by: Yingfeng Zheng, et al.
Published: (2012-01-01)

Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes
by: T. Berney
Published: (2019-10-01)

Third-party Reimbursement of Pharmacist-Led Cardiovascular and Diabetes Preventive Health Services for Workplace Health Initiatives: A Narrative Systematic Review
by: Brandon Tong, et al.
Published: (2021-01-01)

Worldwide increase in diabetes: implications for tuberculosis control
by: Fisher-Hoch SP
Published: (2014-07-01)

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
by: Féline E. V. Scheijmans, et al.
Published: (2022-11-01)

Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
by: Ming-Chieh Hsieh, et al.
Published: (2022-01-01)

Roles and reimbursement of pharmacists as South Africa transitions towards Universal Health Coverage (UHC): An online survey-based study.
by: Vivian Naidoo, et al.
Published: (2021-01-01)

Rhinocerebral mucormycosis to the rise? The impact of the worldwide diabetes epidemic,
by: Erick Martínez-Herrera, et al.
Published: (2021-05-01)

The History of Reimbursements in Neurology
by: Shaheen E Lakhan, et al.
Published: (2013-11-01)

The effects of reimbursement reform of antidiabetic medicines from the patients’ perspective – a survey among patients with type 2 diabetes in Finland
by: Taika Suviranta, et al.
Published: (2019-10-01)

Benefit Assessment and Reimbursement of Digital Health Applications: Concepts for Setting Up a New System for Public Coverage
by: Hendrikje Lantzsch, et al.
Published: (2022-04-01)

Vaccine coverage in children, adolescents and adults with type 1 diabetes and their close contacts in Crete
by: Victoria Giatraki, et al.
Published: (2021-11-01)

Stratified Medicine and Reimbursement Issues
by: Hans-Joerg eFugel, et al.
Published: (2012-10-01)

Vulvar biopsy reimbursement rates
by: Christina N. Kraus, MD, et al.
Published: (2022-10-01)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022-06-01)

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
by: A. S. Kolbin, et al.
Published: (2016-04-01)

Corrigendum to Health Insurance Reimbursement to Hospitals in Vietnam: Policy Implementation Results and Challenges
Published: (2021-05-01)

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
by: Sarah Sharman Moser, et al.
Published: (2023-02-01)

Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4)
by: E. A. J. M. Spaans, et al.
Published: (2018-08-01)

Predicting health behavior in response to the coronavirus disease (COVID-19): Worldwide survey results from early March 2020.
by: David Anaki, et al.
Published: (2021-01-01)

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
by: Tamás Ágh, et al.
Published: (2022-06-01)

Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea
by: Siin Kim, et al.
Published: (2022-08-01)

Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus
by: Ta-Chuan Hung, et al.
Published: (2017-03-01)

Attitude to future and attitude to disease in adolescents with insulin-dependent diabetes
by: Anna A. Kislykh, et al.
Published: (2023-09-01)

International forms of contract : reimbursable contracts
by: Institution of Chemical Engineers
Published: (2007)

Equivalent Modes of Reimbursement in Augmented Contests
by: Chen Cohen, et al.
Published: (2023-03-01)

The Impact of the Clinical Miscoding on Inpatient Reimbursement
by: Roghayeh Ershad Sarabi, et al.
Published: (2020-03-01)

Reimbursement of funeral costs in Roman law
by: Stanojlović Vukašin N.
Published: (2022-01-01)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022-03-01)

Medicines Compliance and Reimbursement Level in Portugal
by: Maria da Conceição Constantino Portela, et al.
Published: (2015-08-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
by: Nancy Samir Elbarbary, et al.
Published: (2021-11-01)

Epidemiology of Type 1 Diabetes Mellitus in Korea through an Investigation of the National Registration Project of Type 1 Diabetes for the Reimbursement of Glucometer Strips with Additional Analyses Using Claims Data
by: Sun Ok Song, et al.
Published: (2016-01-01)

A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures
by: Thérèse Eriksson, et al.
Published: (2020-08-01)

Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
by: Claudio Jommi, et al.
Published: (2023-05-01)

Assessing the clinical utility of the diabetes eating problem survey‐revised (DEPS‐R) in adolescents with type 1 diabetes
by: Brianna Ryman, et al.
Published: (2019-07-01)

Relationships with Mother and Peers in Pre-Adolescent Children with Insulin-Dependent Diabetes
by: R.A. Sabitova, et al.
Published: (2023-10-01)